HomeEIGRQ • OTCMKTS
add
Eiger Biopharmaceuticals Inc
Previous close
$2.40
Day range
$2.03 - $2.42
Year range
$1.61 - $4.19
Market cap
3.18M USD
Avg Volume
244.92K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.80M | 41.06% |
Operating expense | 16.32M | -39.17% |
Net income | -13.45M | 46.48% |
Net profit margin | -353.77 | 62.06% |
Earnings per share | — | — |
EBITDA | -12.56M | 48.53% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.84M | -75.03% |
Total assets | 38.83M | -67.68% |
Total liabilities | 53.28M | -17.81% |
Total equity | -14.46M | — |
Shares outstanding | 1.48M | — |
Price to book | -0.25 | — |
Return on assets | -66.75% | — |
Return on capital | -95.44% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -13.45M | 46.48% |
Cash from operations | -13.95M | 37.28% |
Cash from investing | 12.00M | -44.95% |
Cash from financing | 7.00K | 111.67% |
Net change in cash | -2.06M | -304.12% |
Free cash flow | -13.95M | -8.57% |
About
Founded
2000
Headquarters
Website
Employees
25